Stay updated with breaking news from Fibrotic Progression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New presentations to inform applications for ropeginterferon alfa-2b in the treatment of PVBURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific p...
Presentations to illustrate long-term results from the PROUD/CONTINUATION studies as well as new insights on ropeginterferon alfa-2b in polycythemia vera (PV) patients in JapanTAIPEI--(BUSINESS WIRE)--PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep experti...
Presentations to illustrate long-term results from the PROUD/CONTINUATION studies as well as new insights on ropeginterferon alfa-2b in polycythemia vera (PV) patients in Japan PharmaEssentia Corporation